Page last updated: 2024-08-23

captopril and Experimental Lung Inflammation

captopril has been researched along with Experimental Lung Inflammation in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Bolduc, DL; Bouten, RM; Day, RM; George, J; Mattapallil, JJ; McCart, EA; Mog, SR; Mungunsukh, O; Panganiban, RAM; Rittase, WB; Snow, AL1
Askari, VR; Boskabadi, J; Boskabady, MH; Hosseini, M1
Chang, CH; Lai, MS; Lee, YC; Lin, JW; Lin, MS; Ruan, SY; Wu, LC1
Blair, AE; Broadley, KJ; Bugert, JJ; Ford, WR; Kidd, EJ1
Behnia, R; Jalali, N; Lin, PJ; Ward, WF; Wong, PS1
Domínguez Alvarez, LM; Fernández Seara, J; Pereira Jorge, JA; Rodríguez Canal, A; Rodríguez Pérez, R1

Other Studies

6 other study(ies) available for captopril and Experimental Lung Inflammation

ArticleYear
Captopril reduces lung inflammation and accelerated senescence in response to thoracic radiation in mice.
    Journal of radiation research, 2021, Mar-10, Volume: 62, Issue:2

    Topics: Aging; Animals; Apoptosis; Biomarkers; Captopril; Cytokines; Female; Inflammation Mediators; Lung; Macrophages, Alveolar; Mice, Inbred CBA; Pneumonia; Pulmonary Fibrosis; Spleen; Survival Analysis; Thorax; Whole-Body Irradiation; X-Rays

2021
Immunomodulatory properties of captopril, an ACE inhibitor, on LPS-induced lung inflammation and fibrosis as well as oxidative stress.
    Inflammopharmacology, 2019, Volume: 27, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Biomarkers; Captopril; Cytokines; Fibrosis; Immunologic Factors; Lipopolysaccharides; Lung; Lung Injury; Male; Neutrophils; Oxidative Stress; Pneumonia; Rats; Rats, Wistar

2019
Comparing individual angiotensin-converting enzyme inhibitors with losartan in the risk of hospitalization for pneumonia and related mortality: a nationwide cohort study.
    Journal of hypertension, 2015, Volume: 33, Issue:3

    Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cohort Studies; Enalapril; Female; Hospitalization; Humans; Incidence; Losartan; Male; Middle Aged; Pneumonia; Ramipril; Risk; Taiwan

2015
Bradykinin-induced lung inflammation and bronchoconstriction: role in parainfluenze-3 virus-induced inflammation and airway hyperreactivity.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:3

    Topics: Animals; Bradykinin; Bradykinin B2 Receptor Antagonists; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Captopril; Cell Count; Glycopeptides; Guinea Pigs; Histamine; Male; Ornithine; Ovalbumin; Parainfluenza Virus 3, Human; Peptides; Plethysmography, Whole Body; Pneumonia; Protease Inhibitors; Respirovirus Infections; Sulfonamides; Tissue Kallikreins

2010
Radiation pneumonitis in rats and its modification by the angiotensin-converting enzyme inhibitor captopril evaluated by high-resolution computed tomography.
    Radiation research, 1993, Volume: 135, Issue:1

    Topics: Animals; Blood Pressure; Captopril; Lung; Male; Myocardium; Organ Size; Pneumonia; Radiation Injuries, Experimental; Rats; Rats, Sprague-Dawley; Tomography, X-Ray Computed; X-Rays

1993
[Agranulocytosis induced by captopril after 4 months of treatment].
    Anales de medicina interna (Madrid, Spain : 1984), 1991, Volume: 8, Issue:8

    Topics: Agranulocytosis; Captopril; Diabetes Mellitus, Type 1; Disease Susceptibility; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Pneumonia; Pseudomonas Infections

1991